Large-scale testing (Phase 3)Study completedNCT00644969What this trial is testingSmoking Cessation Study for Patients With Schizophrenia or Schizoaffective DisorderWho this might be right forSmoking Cessation Pfizer 128
Testing effectiveness (Phase 2)Study completedNCT04512066What this trial is testingA Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective DisorderWho this might be right forSchizophrenia, Schizoaffective Disorder Hoffmann-La Roche 287
Post-approval studies (Phase 4)Study completedNCT01855074What this trial is testingAn Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective DisordersWho this might be right forSchizophreniaSchizophreniform DisorderSchizoaffective Disorder Janssen-Cilag Ltd. 80
Not applicableStudy completedNCT01152697What this trial is testingCustomized Adherence Enhancement Plus Long-acting Injectable AntipsychoticWho this might be right forPatient Noncompliance University Hospitals Cleveland Medical Center 30
Early research (Phase 1)Study completedNCT06319170What this trial is testingOpen-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective DisorderWho this might be right forSchizophrenia, Schizoaffective Disorder Teva Branded Pharmaceutical Products R&D LLC 106
Post-approval studies (Phase 4)Study completedNCT00406315What this trial is testingStudy Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To ZiprasidoneWho this might be right forSchizophreniaSchizoaffective Disorder Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 255
Testing effectiveness (Phase 2)Study completedNCT00650611What this trial is testingThe Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic DisordersWho this might be right forSchizophreniaBipolar DisorderSchizoaffective Disorder Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 63
Large-scale testing (Phase 3)Study completedNCT00210691What this trial is testingLong-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderWho this might be right forSchizophrenia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 273
Early research (Phase 1)Study completedNCT02567370What this trial is testingSingle-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581Who this might be right forSchizophrenia or Schizoaffective Disorder Amgen 70
Not applicableEnded earlyNCT04775407What this trial is testingCOVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of DenmarkWho this might be right forCovid19Severe Mental Disorder Anders Fink-Jensen, MD, DMSci 1,355
Not applicableStudy completedNCT01028196What this trial is testingObservational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or DepressionWho this might be right forSchizophreniaSchizoaffective DisorderRecurrent Depression AstraZeneca 750
Testing effectiveness (Phase 2)UnknownNCT03369795What this trial is testingAdd-on Methotrexate for the Treatment of SchizophreniaWho this might be right forSchizophrenia Sheba Medical Center 100
Post-approval studies (Phase 4)Study completedNCT00202293What this trial is testingComparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic FeaturesWho this might be right forBipolar DisorderSchizoaffective Disorder Melbourne Health 83
Large-scale testing (Phase 3)Study completedNCT00283179What this trial is testingAripiprazole in the Treatment of Acutely Relapsed Patients With SchizophreniaWho this might be right forSchizophreniaSchizoaffective Disorder Taiwan Otsuka Pharm. Co., Ltd 83
Early research (Phase 1)Study completedNCT02091388What this trial is testingBioavailability of LY03004 and Risperdal® Consta®Who this might be right forSchizophreniaSchizoaffective Disorder Luye Pharma Group Ltd. 108
Testing effectiveness (Phase 2)Study completedNCT00480571What this trial is testingSafety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective DisorderWho this might be right forSchizophreniaSchizoaffective Disorder BioLineRx, Ltd. 90
Post-approval studies (Phase 4)Study completedNCT00535145What this trial is testingStudy to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver DiseaseWho this might be right forSchizophreniaSchizoaffective DisorderPsychotic Disorders Ortho-McNeil Janssen Scientific Affairs, LLC 121
Early research (Phase 1)WithdrawnNCT00892021What this trial is testingStudy Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective DisorderWho this might be right forSchizophrenia Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)Study completedNCT02504476What this trial is testingMultiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or SchizoaffectiveWho this might be right forSchizophrenia or Schizoaffective Disorder Amgen 52
Large-scale testing (Phase 3)Study completedNCT00328978What this trial is testingSeroquel STACK Study in Schizophrenic or Schizoaffective SubjectsWho this might be right forSchizophreniaSchizoaffective Disorders AstraZeneca 330